1. Home
  2. ATNM vs CVGI Comparison

ATNM vs CVGI Comparison

Compare ATNM & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.11

Market Cap

36.8M

Sector

Health Care

ML Signal

HOLD

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$3.57

Market Cap

59.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
CVGI
Founded
2000
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
59.5M
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
ATNM
CVGI
Price
$1.11
$3.57
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
107.1K
1.0M
Earning Date
01-01-0001
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
30.60
316.18
EPS
N/A
0.04
Revenue
$81,000.00
$755,231,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.47
P/E Ratio
N/A
$72.50
Revenue Growth
N/A
14.06
52 Week Low
$1.02
$0.81
52 Week High
$1.95
$2.94

Technical Indicators

Market Signals
Indicator
ATNM
CVGI
Relative Strength Index (RSI) 43.72 84.66
Support Level $1.02 $1.49
Resistance Level $1.25 N/A
Average True Range (ATR) 0.07 0.26
MACD 0.00 0.18
Stochastic Oscillator 29.73 98.16

Price Performance

Historical Comparison
ATNM
CVGI

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

Share on Social Networks: